Monica Ronzoni
Overview
Explore the profile of Monica Ronzoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1461
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Della Corte A, Mori M, Calabrese F, Palumbo D, Ratti F, Palazzo G, et al.
Int J Hyperthermia
. 2024 May;
41(1):2349059.
PMID: 38754994
Purpose: Radiomics may aid in predicting prognosis in patients with colorectal liver metastases (CLM). Consistent data is available on CT, yet limited data is available on MRI. This study assesses...
2.
Lonardi S, Rasola C, Lobefaro R, Rossini D, Formica V, Scartozzi M, et al.
J Clin Oncol
. 2023 Aug;
41(34):5263-5273.
PMID: 37535876
Purpose: To verify whether both doublet chemotherapy with a modified schedule of fluorouracil, leucovorin, and oxaliplatin (mFOLFOX) and monochemotherapy with fluorouracil plus leucovorin (5-FU + LV) achieve satisfactory efficacy when...
3.
Vitiello F, Cereda S, Foti S, Liscia N, Mazza E, Ronzoni M, et al.
Immunol Med
. 2023 Jun;
47(1):1-5.
PMID: 37293784
Small bowel adenocarcinoma (SBA) is a rare tumor with an unfavorable prognosis, and due to its rarity, few studies on its treatment are available. Chemotherapy remains the standard of treatment...
4.
Prete A, Manca P, Messina M, Formica V, Frassineti G, Zampino M, et al.
Eur J Cancer
. 2023 Feb;
182:87-97.
PMID: 36753836
Background: Molecular characteristics of squamous cell anal carcinoma (SCAC) are poorly explored. Immune checkpoint inhibitors showed limited activity in phase I/II trials, but predictive and prognostic biomarkers are lacking. Patients...
5.
De Cobelli F, Calandri M, Della Corte A, Sirovich R, Gazzera C, Della Vigna P, et al.
Eur Radiol
. 2022 Jan;
32(6):4147-4159.
PMID: 35092474
Objectives: Oligometastatic colorectal cancer benefits of locoregional treatments but data concerning microwave ablation (MWA) are limited and interactions with systemic therapy are still debated. The aim of this study is...
6.
Lonardi S, Prete A, Morano F, Messina M, Formica V, Corsi D, et al.
J Immunother Cancer
. 2021 Nov;
9(11).
PMID: 34815354
Background: No standard therapies beyond first line are established for advanced squamous cell anal carcinoma (aSCAC). Earlier preliminary data suggest activity of epidermal growth factor receptor (EGFR) inhibition and programmed...
7.
Ratti F, Cipriani F, Fiorentini G, Burgio V, Ronzoni M, Della Corte A, et al.
Cancers (Basel)
. 2021 Apr;
13(5).
PMID: 33803257
Background: In recent years, the treatment of colorectal liver metastases (CRLM) has undergone significant evolution thanks to technical improvements as well as oncological advances, which have been the subject of...
8.
Rosati G, Lonardi S, Galli F, Di Bartolomeo M, Ronzoni M, Zampino M, et al.
Eur J Cancer
. 2021 Mar;
148:190-201.
PMID: 33744715
Background: Previous studies on oxaliplatin and fluoropyrimidines as adjuvant therapy in older patients with stage III colon cancer (CC) produced conflicting results. Patients And Methods: We assessed the impact of...
9.
Munoz-Martinez S, Sapena V, Forner A, Nault J, Sapisochin G, Rimassa L, et al.
JHEP Rep
. 2021 Mar;
3(3):100260.
PMID: 33644725
Background & Aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated...
10.
Galbiati S, Damin F, Brambilla D, Ferraro L, Soriani N, Ferretti A, et al.
Pharmaceuticals (Basel)
. 2021 Feb;
14(2).
PMID: 33562158
It is widely accepted that assessing circular tumor DNA (ctDNA) in the plasma of cancer patients is a promising practice to evaluate somatic mutations from solid tumors noninvasively. Recently, it...